We are live on
!
Find out more
TSC
Two Seas Capital Portfolio holdings
AUM
$8.68B
1-Year Est. Return
78.08%
This Fund
S&P 500
This Quarter
Est. Return
-7.86%
1 Year Est. Return
+78.08%
3 Year Est. Return
+344.2%
5 Year Est. Return
+575.95%
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$10.9M
(-8.4%)
Cap. Flow
+$2.77M
Cap. Flow
% of AUM
2.32%
Top 10 Holdings %
Top 10 Hldgs %
99.55%
Holding
14
New
1
Increased
5
Reduced
3
Closed
2
Avg Time Held Equity + Options
0.9
quarters
Top 10 Avg Time Held Equity + Options
0.8
quarters
Top 20 Avg Time Held Equity + Options
0.9
quarters
Avg Time Held Equity only
1
quarter
Top 10 Avg Time Held Equity only
0.9
quarters
Top 20 Avg Time Held Equity only
1
quarter
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arbutus Biopharma
ABUS
|
+$4.2M |
| 2 |
Roivant Sciences
ROIV
|
+$3.27M |
| 3 |
MTBL
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
|
+$2.79M |
| 4 |
JOBS
51job Inc
JOBS
|
+$695K |
| 5 |
Octave Specialty Group
OSG
|
+$610K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hertz
HTZ
|
+$4.31M |
| 2 |
Eagle Pharmaceuticals, Inc.
EGRX
|
+$2.3M |
| 3 |
Sonos
SONO
|
+$1.3M |
| 4 |
CO
Global Cord Blood Corporation
CO
|
+$519K |
| 5 |
ENDP
Endo International plc
ENDP
|
+$384K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 75.29% |
| 2 | Healthcare | 9.2% |
| 3 | Technology | 7.84% |
| 4 | Materials | 4.36% |
| 5 | Financials | 2.03% |
Similar funds
PGFC
GA
AAF
CB
HKAM
SP
MT
ASN
Two Seas Capital's Q1 2022 Portfolio in Review
As of Q1 2022, Two Seas Capital held 14 positions worth $119M, down 8.4% from $130M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Two Seas Capital's Q1 2022 filing shows 1 new, 5 increased, 3 reduced and 2 closed positions. The largest sale was Hertz, an estimated $4.31M.
By sector, the portfolio is most concentrated in Industrials at 75% of assets, down from 81% a quarter earlier, followed by Healthcare and Technology.
- Two Seas Capital added most to Arbutus Biopharma in Q1 2022, an estimated $4.2M increase.
- Two Seas Capital's biggest Q1 2022 reduction was Hertz, cutting an estimated $4.31M.
- Two Seas Capital fully exited Eagle Pharmaceuticals, Inc. in Q1 2022, selling an estimated $2.3M.
- Two Seas Capital's ten largest holdings make up 100% of its $119M portfolio in Q1 2022.
- Two Seas Capital opened 1 new position and closed 2 in Q1 2022.
- Two Seas Capital's portfolio value fell 8.4% quarter-over-quarter to $119M.
Based on Two Seas Capital's 13F filing for Q1 2022, filed 13 May 2022.